Biomarin Pharmaceuticals(BMRN-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | 0.55 | 0.61 | 2.47 | 3.02 |
| Number of Estimates | 12 | 8 | 13 | 12 |
| High Estimate | 0.63 | 0.77 | 2.60 | 4.17 |
| Low Estimate | 0.49 | 0.41 | 2.30 | 1.81 |
| Prior Year | 0.26 | 0.49 | 1.23 | 2.47 |
| Growth Rate Est. (year over year) | +111.54% | +24.49% | +100.81% | +22.27% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $0.74 | $0.77 | $0.49 | $0.26 |
| Estimate | $0.57 | $0.38 | $0.37 | $0.24 |
| Difference | +0.17 | +0.39 | +0.12 | +0.02 |
| Surprise | +29.82% | +102.63% | +32.43% | +8.33% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.44
3 Mths Ago25
4.52
2 Mths Ago25
4.50
1 Mth Ago26
4.44
Current27
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 25 | 25 | 26 | 27 |
18 | 19 | 19 1 | 19 1 | |
| Holds | 7 | 6 | 6 | 7 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell